Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy
Source: Leukemia Research - Category: Hematology Authors: TaeHyung Kim, Marc S. Tyndel, Zhaolei Zhang, Jaesook Ahn, Seunghyun Choi, Michael Szardenings, Jeffrey H. Lipton, Hyeoung-Joon Kim, Dennis (Dong Hwan) Kim Tags: Research paper Source Type: research